Libby Echo:Prio

K220956

Dyad Medical, Inc · cleared 2022-07-20 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
Libby™ Echo:Prio is software that is used to process previously acquired DICOM-compliant cardiac ultrasound images, and to make measurements on these images in order to provide automated estimation of several cardiac measurements.
AlgorithmMachine learning based view classification and border segmentation
source quote (p.5)
Machine learning based view classification and border segmentation form the basis for this automated analysis.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.7)
in addition to the FDA Guidance documents, “Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" and "Content of Premarket Submission for Management of Cybersecurity in Medical Devices.”

Validation studies (1)

Retrospective clinical

sample size not stated

endpoints: view classification accuracy; F1 value; sensitivity; specificity; HR output estimate; ED/ES identification; Ejection Fraction (EF) prediction

standards: NEMA PS 3.1 - 3.20 2021e Digital Imaging and Communications in Medicine (DICOM) Set, IEC 62304:2006/A1:2016 Medical device software - Software life cycle processes, ISO 14971:2019 Medical Devices -- Application of Risk Management to Medical Devices, IEC 62366-1 Edition 1.1 2020-06 Medical Devices -- Part 1: Application of Usability Engineering to Medical Devices, ISO 15223-1 Medical devices -- Symbols to be used with medical device labels, labelling and information to be supplied -- Part 1: General requirements

Reported performance (4 observations)

sensitivity96.8
source quote (p.7)
The testing demonstrated view classification accuracy of 97% with an average F1 value of >96.6%, average sensitivity (Sn) of 96.8% and average Specificity (Sp) of 98.5%.
specificity98.5
source quote (p.7)
The testing demonstrated view classification accuracy of 97% with an average F1 value of >96.6%, average sensitivity (Sn) of 96.8% and average Specificity (Sp) of 98.5%.
accuracyas written: “view classification accuracy97
source quote (p.7)
The testing demonstrated view classification accuracy of 97% with an average F1 value of >96.6%, average sensitivity (Sn) of 96.8% and average Specificity (Sp) of 98.5%.
f1as written: “F1 value96.6
source quote (p.7)
The testing demonstrated view classification accuracy of 97% with an average F1 value of >96.6%, average sensitivity (Sn) of 96.8% and average Specificity (Sp) of 98.5%.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K220956